{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:31:19Z","timestamp":1787797879799,"version":"build-2784847793"},"reference-count":110,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"abstract":"<jats:p>Childhood cancer survivors are at increased risk of developing (long-term) skeletal adverse effects, such as osteonecrosis, impaired bone mineral density, and fractures. This paper provides an overview of the current understanding of bone health in these survivors, examining whether it represents a significant concern. It focusses on the challenges of assessing and managing bone health in childhood cancer survivors, highlighting diagnostic pitfalls, methods for accurately identifying those at high risk, and suggested strategies for the surveillance and management of osteonecrosis and impaired bone mineral density. The need for improved surveillance strategies, particularly for high-risk survivors, alongside potential prevention and management options, including pharmacological and lifestyle interventions, is emphasised. Given the lack of consensus on optimal prevention and treatment strategies, the paper emphasises the need for further research to optimise care and improve long-term outcomes for childhood cancer survivors with bone health impairments.<\/jats:p>","DOI":"10.1530\/ec-24-0487","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T14:49:55Z","timestamp":1729608595000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":2,"title":["Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density"],"prefix":"10.1530","volume":"13","author":[{"given":"Demi T C","family":"de Winter","sequence":"first","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J C M M","family":"Neggers","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Section Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Division of Child Health, Wilhelmina Children\u2019s Hospital\/University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-0089","authenticated-orcid":true,"given":"Jenneke E","family":"van Atteveld","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Department of Paediatrics, Emma Children's Hospital\/Amsterdam University Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Clinical Oncology","first-page":"3262","article-title":"Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children\u2019s Cancer Group","volume":"18","author":"Mattano","year":"2000","unstructured":"Mattano LAJrSather HNTrigg ME & Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children\u2019s Cancer Group. Journal of Clinical Oncology 2000 18 3262\u20133272. (https:\/\/doi.org\/10.1200\/JCO.2000.18.18.3262)"},{"key":"bib2","series-title":"Cancer","first-page":"3234","article-title":"Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase","volume":"74","author":"Steinherz","year":"1994","unstructured":"Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 1994 74 3234\u20133239. (https:\/\/doi.org\/10.1002\/1097-0142(19941215)74:12<3234::aid-cncr2820741224>3.0.co;2-1)"},{"key":"bib3","series-title":"Haematologica","first-page":"e175","article-title":"Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia","volume":"102","author":"Mogensen","year":"2017","unstructured":"Mogensen SSSchmiegelow KGrell KAlbertsen BKWehner PSKampmann P & Frandsen TL. Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia. Haematologica 2017 102 e175\u2013e178. (https:\/\/doi.org\/10.3324\/haematol.2016.160507)"},{"key":"bib4","series-title":"Journal of Bone and Joint Surgery","first-page":"1054","article-title":"Steroid-induced adipogenesis in a pluripotential cell line from bone marrow","volume":"79","author":"Cui","year":"1997","unstructured":"Cui QWang GJ & Balian G. Steroid-induced adipogenesis in a pluripotential cell line from bone marrow. Journal of Bone and Joint Surgery 1997 79 1054\u20131063. (https:\/\/doi.org\/10.2106\/00004623-199707000-00012)"},{"key":"bib5","series-title":"Chinese Medical Journal","first-page":"581","article-title":"Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis","volume":"119","author":"Yin","year":"2006","unstructured":"Yin LLi YB & Wang YS. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chinese Medical Journal 2006 119 581\u2013588. (https:\/\/doi.org\/10.1097\/00029330-200604010-00012)"},{"key":"bib6","series-title":"Haematologica","first-page":"1570","article-title":"Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia","volume":"93","author":"te Winkel","year":"2008","unstructured":"te Winkel MLAppel IMPieters R & van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica 2008 93 1570\u20131574. (https:\/\/doi.org\/10.3324\/haematol.12956)"},{"key":"bib7","series-title":"Haematologica","first-page":"1295","article-title":"Osteonecrosis in children with acute lymphoblastic leukemia","volume":"101","author":"Kunstreich","year":"2016","unstructured":"Kunstreich MKummer SLaws H-JBorkhardt A & Kuhlen M. Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica 2016 101 1295\u20131305. (https:\/\/doi.org\/10.3324\/haematol.2016.147595)"},{"key":"bib8","series-title":"Leukemia and Lymphoma","first-page":"78","article-title":"Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy","volume":"60","author":"Krull","year":"2019","unstructured":"Krull KKunstreich MBronsema ABleckmann KClassen CFErdlenbruch BJorch NKolb RLeipold AMoser O, et al. Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy. Leukemia and Lymphoma 2019 60 78\u201384. (https:\/\/doi.org\/10.1080\/10428194.2018.1466292)"},{"key":"bib9","series-title":"Journal of Clinical Oncology","first-page":"4143","article-title":"Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia","volume":"29","author":"te Winkel","year":"2011","unstructured":"te Winkel MLPieters RHop WCJde Groot-Kruseman HALequin MHvan der Sluis IMB\u00f6kkerink JPMLeeuw JABruin MCAEgeler RM, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. Journal of Clinical Oncology 2011 29 4143\u20134150. (https:\/\/doi.org\/10.1200\/JCO.2011.37.3217)"},{"key":"bib10","series-title":"British Journal of Haematology","first-page":"e177","article-title":"Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia","volume":"189","author":"Inaba","year":"2020","unstructured":"Inaba HCao XChang JYKarol SEPanetta JCNess KKCheng CPui CHRelling MV & Kaste SC. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia. British Journal of Haematology 2020 189 e177\u2013e181. (https:\/\/doi.org\/10.1111\/bjh.16589)"},{"key":"bib11","series-title":"Lancet. Oncology","first-page":"906","article-title":"Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial","volume":"13","author":"Mattano","year":"2012","unstructured":"Mattano LAJrDevidas MNachman JBSather HNHunger SPSteinherz PGGaynon PSSeibel NL & Children\u2019s Oncology Group. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet. Oncology 2012 13 906\u2013915. (https:\/\/doi.org\/10.1016\/S1470-2045(12)70274-7)"},{"key":"bib12","series-title":"Journal of Clinical Oncology","first-page":"1202","article-title":"Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00\u201301","volume":"31","author":"Vrooman","year":"2013","unstructured":"Vrooman LMStevenson KESupko JGO\u2019Brien JDahlberg SEAsselin BLAthale UHClavell LAKelly KMKutok JL, et al. Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00\u201301. Journal of Clinical Oncology 2013 31 1202\u20131210. (https:\/\/doi.org\/10.1200\/JCO.2012.43.2070)"},{"key":"bib13","series-title":"Physical Therapy","first-page":"509","article-title":"Long-term functional outcomes among childhood survivors of cancer who have a history of osteonecrosis","volume":"100","author":"DeFeo","year":"2020","unstructured":"DeFeo BMKaste SCLi ZBrinkman TMNeel MDSrivastava DKHudson MMRobison LLKarol SE & Ness KK. Long-term functional outcomes among childhood survivors of cancer who have a history of osteonecrosis. Physical Therapy 2020 100 509\u2013522. (https:\/\/doi.org\/10.1093\/ptj\/pzz176)"},{"key":"bib14","series-title":"Nature Medicine","first-page":"1340","article-title":"A joint international consensus statement for measuring quality of survival for patients with childhood cancer","volume":"29","author":"van Kalsbeek","year":"2023","unstructured":"van Kalsbeek RJHudson MMMulder RLEhrhardt MGreen DMMulrooney DAHakkert Jden Hartogh JNijenhuis Avan Santen HM, et al. A joint international consensus statement for measuring quality of survival for patients with childhood cancer. Nature Medicine 2023 29 1340\u20131348. (https:\/\/doi.org\/10.1038\/s41591-023-02339-y)"},{"key":"bib15","series-title":"Clinical Radiology","first-page":"1079","article-title":"MRI of osteonecrosis","volume":"59","author":"Saini","year":"2004","unstructured":"Saini A & Saifuddin A. MRI of osteonecrosis. Clinical Radiology 2004 59 1079\u20131093. (https:\/\/doi.org\/10.1016\/j.crad.2004.04.014)"},{"key":"bib16","series-title":"Pediatric Blood and Cancer","first-page":"198","article-title":"The diagnosis and classification of osteonecrosis in patients with childhood leukemia","volume":"62","author":"Niinim\u00e4ki","year":"2015","unstructured":"Niinim\u00e4ki THarila-Saari A & Niinim\u00e4ki R. The diagnosis and classification of osteonecrosis in patients with childhood leukemia. Pediatric Blood and Cancer 2015 62 198\u2013203. (https:\/\/doi.org\/10.1002\/pbc.25295)"},{"key":"bib17","series-title":"Clinical Radiology","first-page":"1439","article-title":"The classification of osteonecrosis in patients with cancer: validation of a new radiological classification system","volume":"70","author":"Niinim\u00e4ki","year":"2015","unstructured":"Niinim\u00e4ki TNiinim\u00e4ki JHalonen JH\u00e4nninen PHarila-Saari A & Niinim\u00e4ki R. The classification of osteonecrosis in patients with cancer: validation of a new radiological classification system. Clinical Radiology 2015 70 1439\u20131444. (https:\/\/doi.org\/10.1016\/j.crad.2015.08.011)"},{"key":"bib18","series-title":"Lancet. Oncology","first-page":"e231","article-title":"Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus","volume":"17","author":"Schmiegelow","year":"2016","unstructured":"Schmiegelow KAttarbaschi ABarzilai SEscherich GFrandsen TLHalsey CHough RJeha SKato MLiang D-C, et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet. Oncology 2016 17 e231\u2013e239. (https:\/\/doi.org\/10.1016\/S1470-2045(16)30035-3)"},{"key":"bib19","series-title":"Haematologica","first-page":"1198","article-title":"Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols","volume":"106","author":"van Atteveld","year":"2021","unstructured":"van Atteveld JEde Groot-Kruseman HAFiocco MLequin MHNeggers SJCMMPluijm SMFvan der Sluis IMPieters R & van den Heuvel-Eibrink MM. Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols. Haematologica 2021 106 1198\u20131201. (https:\/\/doi.org\/10.3324\/haematol.2020.257550)"},{"key":"bib20","series-title":"Blood Advances","first-page":"72","article-title":"Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials","volume":"6","author":"Valtis","year":"2022","unstructured":"Valtis YKStevenson KEPlace AESilverman LBVrooman LMGotti GBrunner AMNauffal MDeAngelo DJ & Luskin MR. Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials. Blood Advances 2022 6 72\u201381. (https:\/\/doi.org\/10.1182\/bloodadvances.2021005278)"},{"key":"bib21","series-title":"Journal of Clinical Oncology","first-page":"1498","article-title":"High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia","volume":"25","author":"Niinim\u00e4ki","year":"2007","unstructured":"Niinim\u00e4ki RAHarila-Saari AHJartti AESeuri RMRiikonen PVP\u00e4\u00e4kk\u00f6 ELM\u00f6tt\u00f6nen MI & Lanning M. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. Journal of Clinical Oncology 2007 25 1498\u20131504. (https:\/\/doi.org\/10.1200\/JCO.2006.06.2539)"},{"key":"bib22","series-title":"Blood","first-page":"983","article-title":"Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia","volume":"134","author":"Janke","year":"2019","unstructured":"Janke LJVan Driest SLPortera MVAtreya RVDenny JCPei DCheng CKaste SCInaba HJeha S, et al. Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemia. Blood 2019 134 983\u2013986. (https:\/\/doi.org\/10.1182\/blood.2019000006)"},{"key":"bib23","series-title":"Pediatric Blood and Cancer","first-page":"e30683","article-title":"Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"70","author":"Laumann","year":"2023","unstructured":"Laumann RDPedersen LLAndr\u00e9s-Jensen LM\u00f8lgaard CSchmiegelow KFrandsen TL & Als-Nielsen B. Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: a systematic review and meta-analysis. Pediatric Blood and Cancer 2023 70 e30683. (https:\/\/doi.org\/10.1002\/pbc.30683)"},{"key":"bib24","series-title":"Haematologica","first-page":"1564","article-title":"Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia","volume":"100","author":"den Hoed","year":"2015","unstructured":"den Hoed MAHPluijm SMFte Winkel MLde Groot-Kruseman HAFiocco MHoogerbrugge PLeeuw JABruin MCAvan der Sluis IMBresters D, et al. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica 2015 100 1564\u20131570. (https:\/\/doi.org\/10.3324\/haematol.2015.125583)"},{"key":"bib25","series-title":"Faculty Reviews","first-page":"57","article-title":"Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia","volume":"10","author":"van Atteveld","year":"2021","unstructured":"van Atteveld JEde Winter DTPieters RNeggers SJ & van den Heuvel-Eibrink MM. Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia. Faculty Reviews 2021 10 57. (https:\/\/doi.org\/10.12703\/r\/10-57)"},{"key":"bib26","series-title":"Journal of Bone and Mineral Research","first-page":"1104","article-title":"Reductions in bone mineral density are apparent early in children with prevalent osteonecrosis lesions following leukemia therapy","volume":"38","author":"Halton","year":"2023","unstructured":"Halton JMMa JBabyn PMatzinger MAKaste SCScharke MFernandez CVMiettunen PHo JAlos N, et al. Reductions in bone mineral density are apparent early in children with prevalent osteonecrosis lesions following leukemia therapy. Journal of Bone and Mineral Research 2023 38 1104\u20131115. (https:\/\/doi.org\/10.1002\/jbmr.4870)"},{"key":"bib27","series-title":"Molecular Diagnosis and Therapy","first-page":"519","article-title":"Genetic biomarkers to identify the risk of osteonecrosis in children with acute lymphoblastic leukemia","volume":"20","author":"den Hoed","year":"2016","unstructured":"den Hoed MAHPluijm SMFUitterlinden AGPieters R & van den Heuvel-Eibrink MM. Genetic biomarkers to identify the risk of osteonecrosis in children with acute lymphoblastic leukemia. Molecular Diagnosis and Therapy 2016 20 519\u2013522. (https:\/\/doi.org\/10.1007\/s40291-016-0226-z)"},{"key":"bib28","series-title":"Blood","first-page":"558","article-title":"Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia","volume":"127","author":"Karol","year":"2016","unstructured":"Karol SEMattano LAJrYang WMaloney KWSmith CLiu CRamsey LBFernandez CAChang TYNeale G, et al. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood 2016 127 558\u2013564. (https:\/\/doi.org\/10.1182\/blood-2015-10-673848)"},{"key":"bib29","series-title":"Blood Advances","first-page":"981","article-title":"Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge","volume":"1","author":"Kuhlen","year":"2017","unstructured":"Kuhlen MKunstreich MKrull KMeisel R & Borkhardt A. Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge. Blood Advances 2017 1 981\u2013994. (https:\/\/doi.org\/10.1182\/bloodadvances.2017007286)"},{"key":"bib30","series-title":"Haematologica","first-page":"430","article-title":"Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia","volume":"99","author":"Te Winkel","year":"2014","unstructured":"Te Winkel MLPieters RWind EJDBessems JHJMG & van den Heuvel-Eibrink MM. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia. Haematologica 2014 99 430\u2013436. (https:\/\/doi.org\/10.3324\/haematol.2013.095562)"},{"key":"bib31","series-title":"HemaSphere","first-page":"e544","article-title":"Osteonecrosis in adults with acute lymphoblastic leukemia: an unmet clinical need","volume":"5","author":"Kuhlen","year":"2021","unstructured":"Kuhlen MKunstreich M & G\u00f6kbuget N. Osteonecrosis in adults with acute lymphoblastic leukemia: an unmet clinical need. HemaSphere 2021 5 e544. (https:\/\/doi.org\/10.1097\/HS9.0000000000000544)"},{"key":"bib32","series-title":"Haematologica","first-page":"2095","article-title":"Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice","volume":"106","author":"Finch","year":"2021","unstructured":"Finch ERPayton MAJenkins DACai XLi LKarol SERelling MV & Janke LJ. Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice. Haematologica 2021 106 2095\u20132101. (https:\/\/doi.org\/10.3324\/haematol.2020.252767)"},{"key":"bib33","series-title":"Pediatric Blood and Cancer","first-page":"e28509","article-title":"Team approach: management of osteonecrosis in children with acute lymphoblastic leukemia","volume":"67","author":"Jones","year":"2020","unstructured":"Jones LCKaste SCKarol SEDeFeo BKim HKWNeel MD & Levin AS. Team approach: management of osteonecrosis in children with acute lymphoblastic leukemia. Pediatric Blood and Cancer 2020 67 e28509. (https:\/\/doi.org\/10.1002\/pbc.28509)"},{"key":"bib34","series-title":"Osteoporosis International","first-page":"59","article-title":"Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia","volume":"31","author":"Harris","year":"2020","unstructured":"Harris AMLee AR & Wong SC. Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia. Osteoporosis International 2020 31 59\u201366. (https:\/\/doi.org\/10.1007\/s00198-019-05082-8)"},{"key":"bib35","series-title":"Pediatric Blood and Cancer","first-page":"e29183","article-title":"Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models","volume":"68","author":"Janke","year":"2021","unstructured":"Janke LJKim JPayton MAJenkins DACai XFinch ERLiu YRelling MV & Karol SE. Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models. Pediatric Blood and Cancer 2021 68 e29183. (https:\/\/doi.org\/10.1002\/pbc.29183)"},{"key":"bib36","series-title":"Haematologica","first-page":"605","article-title":"Influence of bisphosphonates or recombinant human parathyroid hormone on in vitro sensitivity of acute lymphoblastic leukemia cells to chemotherapy","volume":"108","author":"De Winter","year":"2023","unstructured":"De Winter DTCVan Atteveld JEBuijs-Gladiness JGCAMPieters RNeggers SJCMMMeijerink JPP & Van den Heuvel-Eibrink MM. Influence of bisphosphonates or recombinant human parathyroid hormone on in vitro sensitivity of acute lymphoblastic leukemia cells to chemotherapy. Haematologica 2023 108 605\u2013609. (https:\/\/doi.org\/10.3324\/haematol.2022.281033)"},{"key":"bib37","series-title":"Pediatric Blood and Cancer","first-page":"e30968","article-title":"A call for a randomized trial of prophylactic bisphosphonate for decreasing the incidence of osteonecrosis in patients with acute lymphoblastic leukemia","volume":"71","author":"Bostrom","year":"2024","unstructured":"Bostrom B. A call for a randomized trial of prophylactic bisphosphonate for decreasing the incidence of osteonecrosis in patients with acute lymphoblastic leukemia. Pediatric Blood and Cancer 2024 71 e30968. (https:\/\/doi.org\/10.1002\/pbc.30968)"},{"key":"bib38","series-title":"Bone and Joint Journal","first-page":"589","article-title":"Surgical management of symptomatic osteonecrosis and utility of core decompression of the femoral head in young people with acute lymphoblastic leukaemia recruited into UKALL 2003","volume":"103\u2013B","author":"Amin","year":"2021","unstructured":"Amin NKraft JFishlock AWhite AHolton CKinsey SFeltbower R & James B. Surgical management of symptomatic osteonecrosis and utility of core decompression of the femoral head in young people with acute lymphoblastic leukaemia recruited into UKALL 2003. Bone and Joint Journal 2021 103\u2013B 589\u2013596. (https:\/\/doi.org\/10.1302\/0301-620X.103B3.BJJ-2020-0239.R3)"},{"key":"bib39","series-title":"Hormone Research in Paediatrics","first-page":"137","article-title":"Skeletal morbidity in children and adolescents during and following cancer therapy","volume":"91","author":"Mostoufi-Moab","year":"2019","unstructured":"Mostoufi-Moab S & Ward LM. Skeletal morbidity in children and adolescents during and following cancer therapy. Hormone Research in Paediatrics 2019 91 137\u2013151. (https:\/\/doi.org\/10.1159\/000494809)"},{"key":"bib40","series-title":"Bone","first-page":"223","article-title":"Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol","volume":"59","author":"te Winkel","year":"2014","unstructured":"te Winkel MLPieters RHop WCJRoos JCB\u00f6kkerink JPMLeeuw JABruin MCAKollen WJWVeerman AJPde Groot-Kruseman HA, et al. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. Bone 2014 59 223\u2013228. (https:\/\/doi.org\/10.1016\/j.bone.2013.11.017)"},{"key":"bib41","series-title":"Annals of Pediatric Endocrinology and Metabolism","first-page":"1","article-title":"Bone morbidity in pediatric acute lymphoblastic leukemia","volume":"25","author":"Ahn","year":"2020","unstructured":"Ahn MB & Suh BK. Bone morbidity in pediatric acute lymphoblastic leukemia. Annals of Pediatric Endocrinology and Metabolism 2020 25 1\u20139. (https:\/\/doi.org\/10.6065\/apem.2020.25.1.1)"},{"issue":"Supplement 2","key":"bib42","series-title":"Pediatrics","first-page":"S166","article-title":"Glucocorticoid-induced osteoporosis in children: impact of the underlying disease","volume":"119","author":"Leonard","year":"2007","unstructured":"Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 2007 119(Supplement 2) S166\u2013S174. (https:\/\/doi.org\/10.1542\/peds.2006-2023J)"},{"key":"bib43","series-title":"Current Osteoporosis Reports","first-page":"300","article-title":"Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment","volume":"12","author":"Mostoufi-Moab","year":"2014","unstructured":"Mostoufi-Moab S & Halton J. Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment. Current Osteoporosis Reports 2014 12 300\u2013312. (https:\/\/doi.org\/10.1007\/s11914-014-0222-3)"},{"key":"bib44","series-title":"Journal of Pediatrics","first-page":"204","article-title":"Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia","volume":"141","author":"van der Sluis","year":"2002","unstructured":"van der Sluis IMvan den Heuvel-Eibrink MMH\u00e4hlen KKrenning EP & de Muinck Keizer-Schrama SMPF. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. Journal of Pediatrics 2002 141 204\u2013210. (https:\/\/doi.org\/10.1067\/mpd.2002.125728)"},{"key":"bib45","series-title":"Journal of Bone and Mineral Research","first-page":"1435","article-title":"Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study","volume":"33","author":"Ward","year":"2018","unstructured":"Ward LMMa JLang BHo JAlos NMatzinger MAShenouda NLentle BJaremko JLWilson B, et al. Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study. Journal of Bone and Mineral Research 2018 33 1435\u20131443. (https:\/\/doi.org\/10.1002\/jbmr.3447)"},{"key":"bib46","series-title":"Cancer","first-page":"1025","article-title":"Bone mineral density in children with acute lymphoblastic leukemia","volume":"124","author":"Inaba","year":"2018","unstructured":"Inaba HCao XHan AQPanetta JCNess KKMetzger MLRubnitz JERibeiro RCSandlund JTJeha S, et al. Bone mineral density in children with acute lymphoblastic leukemia. Cancer 2018 124 1025\u20131035. (https:\/\/doi.org\/10.1002\/cncr.31184)"},{"key":"bib47","series-title":"Journal of Bone and Mineral Research","first-page":"2290","article-title":"A validated risk prediction model for bone fragility in children with acute lymphoblastic leukemia","volume":"36","author":"Verwaaijen","year":"2021","unstructured":"Verwaaijen EJMa Jde Groot-Kruseman HAPieters Rvan der Sluis IMvan Atteveld JEHalton JFernandez CVHartman Ade Jonge R, et al. A validated risk prediction model for bone fragility in children with acute lymphoblastic leukemia. Journal of Bone and Mineral Research 2021 36 2290\u20132299. (https:\/\/doi.org\/10.1002\/jbmr.4442)"},{"key":"bib48","series-title":"Osteoporosis International","first-page":"521","article-title":"Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer","volume":"26","author":"den Hoed","year":"2015","unstructured":"den Hoed MAKlap BCte Winkel MLPieters Rvan Waas MNeggers SJCMMBoot AMBlijdorp Kvan Dorp WPluijm SM, et al. Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer. Osteoporosis International 2015 26 521\u2013529. (https:\/\/doi.org\/10.1007\/s00198-014-2878-z)"},{"key":"bib49","series-title":"Endocrine Journal","first-page":"1055","article-title":"Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital","volume":"55","author":"Miyoshi","year":"2008","unstructured":"Miyoshi YOhta HHashii YTokimasa SNamba NMushiake SHara J & Ozono K. Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital. Endocrine Journal 2008 55 1055\u20131063. (https:\/\/doi.org\/10.1507\/endocrj.k08e-075)"},{"key":"bib50","series-title":"Lancet. Diabetes and Endocrinology","first-page":"21","article-title":"Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study","volume":"11","author":"van Atteveld","year":"2023","unstructured":"van Atteveld JEde Winter DTCPluimakers VGFiocco MNievelstein RAJHobbelink MGGde Vries ACHLoonen JJvan Dulmen-den Broeder Evan der Pal HJ, et al. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study. Lancet. Diabetes and Endocrinology 2023 11 21\u201332. (https:\/\/doi.org\/10.1016\/S2213-8587(22)00286-8)"},{"key":"bib51","series-title":"Pediatrics","article-title":"Bone mineral density in survivors of childhood cancer: a meta-analysis","volume":"154","author":"Velentza","year":"2024","unstructured":"Velentza LFilis PWilhelmsson MKogner PHerold N & S\u00e4vendahl L. Bone mineral density in survivors of childhood cancer: a meta-analysis. Pediatrics 2024 154. (https:\/\/doi.org\/10.1542\/peds.2024-066081)"},{"key":"bib52","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"6101","article-title":"Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes","volume":"104","author":"van Iersel","year":"2019","unstructured":"van Iersel LLi ZSrivastava DKBrinkman TMBjornard KLWilson CLGreen DMMerchant TEPui CHHowell RM, et al. Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes. Journal of Clinical Endocrinology and Metabolism 2019 104 6101\u20136115. (https:\/\/doi.org\/10.1210\/jc.2019-00834)"},{"key":"bib53","series-title":"Bone","first-page":"336","article-title":"Peak bone mineral density, lean body mass and fractures","volume":"46","author":"Boot","year":"2010","unstructured":"Boot AMde Ridder MAJvan der Sluis IMvan Slobbe IKrenning EP & Keizer-Schrama SMPFM. Peak bone mineral density, lean body mass and fractures. Bone 2010 46 336\u2013341. (https:\/\/doi.org\/10.1016\/j.bone.2009.10.003)"},{"key":"bib54","series-title":"Journal of Pediatrics","first-page":"261","article-title":"The determinants of peak bone mass.","volume":"180","author":"Gordon","year":"2017","unstructured":"Gordon CMZemel BSWren TALLeonard MBBachrach LKRauch FGilsanz VRosen CJ & Winer KK. The determinants of peak bone mass. Journal of Pediatrics 2017 180 261\u2013269. (https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.056)"},{"key":"bib55","series-title":"Applied Radiation and Isotopes","first-page":"215","article-title":"Radiation exposure in bone mineral density assessment","volume":"50","author":"Njeh","year":"1999","unstructured":"Njeh CFFuerst THans DBlake GM & Genant HK. Radiation exposure in bone mineral density assessment. Applied Radiation and Isotopes 1999 50 215\u2013236. (https:\/\/doi.org\/10.1016\/s0969-8043(98)00026-8)"},{"key":"bib56","series-title":"Osteoporosis International","first-page":"368","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","unstructured":"Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporosis International 1994 4 368\u2013381. (https:\/\/doi.org\/10.1007\/BF01622200)"},{"key":"bib57","series-title":"Journal of Clinical Densitometry","first-page":"453","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","unstructured":"Shuhart CRYeap SSAnderson PAJankowski LGLewiecki EMMorse LRRosen HNWeber DRZemel BS & Shepherd JA. Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. Journal of Clinical Densitometry 2019 22 453\u2013471. (https:\/\/doi.org\/10.1016\/j.jocd.2019.07.001)"},{"key":"bib58","series-title":"Journal of Clinical Densitometry","first-page":"567","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","unstructured":"Weber DRBoyce AGordon CH\u00f6gler WKecskemethy HHMisra MSwolin-Eide DTebben PWard LMWasserman H, et al. The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position. Journal of Clinical Densitometry 2019 22 567\u2013589. (https:\/\/doi.org\/10.1016\/j.jocd.2019.07.002)"},{"key":"bib59","series-title":"Osteoporosis International","first-page":"2735","article-title":"Osteoporosis in young adults: pathophysiology, diagnosis, and management","volume":"23","author":"Ferrari","year":"2012","unstructured":"Ferrari SBianchi MLEisman JAFoldes AJAdami SWahl DAStepan JJde Vernejoul MCKaufman JM & IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology. Osteoporosis in young adults: pathophysiology, diagnosis, and management. Osteoporosis International 2012 23 2735\u20132748. (https:\/\/doi.org\/10.1007\/s00198-012-2030-x)"},{"key":"bib60","author":"Sawyer","year":"2007","unstructured":"Sawyer AJBachrach LK & Fung EB. Bone densitometry in growing patients: guidelines for clinical practice.Totowa, NJ, USA: Humana Press, 2007. (https:\/\/doi.org\/10.1007\/978-1-59745-211-3)"},{"key":"bib61","series-title":"Pediatric Research","first-page":"220","article-title":"Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application","volume":"63","author":"Baroncelli","year":"2008","unstructured":"Baroncelli GI. Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application. Pediatric Research 2008 63 220\u2013228. (https:\/\/doi.org\/10.1203\/PDR.0b013e318163a286)"},{"key":"bib62","series-title":"European Journal of Endocrinology","first-page":"495","article-title":"Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study","volume":"189","author":"Pluimakers","year":"2023","unstructured":"Pluimakers VGvan Atteveld JEde Winter DTCBolier MFiocco MNievelstein RJAJJanssens GORBresters Dvan der Heiden-van der Loo Mde Vries ACH, et al. Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study. European Journal of Endocrinology 2023 189 495\u2013507. (https:\/\/doi.org\/10.1093\/ejendo\/lvad139)"},{"key":"bib63","series-title":"Journal of Clinical Oncology","first-page":"1215","article-title":"Skeletal morbidity in childhood acute lymphoblastic leukemia","volume":"22","author":"Mandel","year":"2004","unstructured":"Mandel KAtkinson SBarr RD & Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology 2004 22 1215\u20131221. (https:\/\/doi.org\/10.1200\/JCO.2004.04.199)"},{"key":"bib64","series-title":"Lancet. Diabetes and Endocrinology","first-page":"622","article-title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"9","author":"van Atteveld","year":"2021","unstructured":"van Atteveld JEMulder RLvan den Heuvel-Eibrink MMHudson MMKremer LCMSkinner RWallace WHConstine LSHigham CEKaste SC, et al. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet. Diabetes and Endocrinology 2021 9 622\u2013637. (https:\/\/doi.org\/10.1016\/S2213-8587(21)00173-X)"},{"key":"bib65","series-title":"Journal of Clinical Oncology","first-page":"2854","article-title":"Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors","volume":"36","author":"Vatner","year":"2018","unstructured":"Vatner RENiemierko AMisra MWeyman EAGoebel CPEbb DHJones RMHuang MSMahajan AGrosshans DR, et al. Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors. Journal of Clinical Oncology 2018 36 2854\u20132862. (https:\/\/doi.org\/10.1200\/JCO.2018.78.1492)"},{"key":"bib66","series-title":"Osteoporosis International","first-page":"1281","article-title":"The National Osteoporosis Foundation\u2019s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","unstructured":"Weaver CMGordon CMJanz KFKalkwarf HJLappe JMLewis RO\u2019Karma MWallace TC & Zemel BS. The National Osteoporosis Foundation\u2019s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporosis International 2016 27 1281\u20131386. (https:\/\/doi.org\/10.1007\/s00198-015-3440-3)"},{"key":"bib67","series-title":"Journal of Clinical Oncology","first-page":"2217","article-title":"Prediction of low and very low bone mineral density among adult survivors of childhood cancer","volume":"37","author":"van Atteveld","year":"2019","unstructured":"van Atteveld JEPluijm SMFNess KKHudson MMChemaitilly WKaste SCRobison LLNeggers SJCMMYasui Yvan den Heuvel-Eibrink MM, et al. Prediction of low and very low bone mineral density among adult survivors of childhood cancer. Journal of Clinical Oncology 2019 37 2217\u20132225. (https:\/\/doi.org\/10.1200\/JCO.18.01917)"},{"key":"bib68","series-title":"Nature Genetics","first-page":"1199","article-title":"Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies","volume":"41","author":"Rivadeneira","year":"2009","unstructured":"Rivadeneira FStyrk\u00e1rsdottir UEstrada KHalld\u00f3rsson BVHsu YHRichards JBZillikens MCKavvoura FKAmin NAulchenko YS, et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nature Genetics 2009 41 1199\u20131206. (https:\/\/doi.org\/10.1038\/ng.446)"},{"key":"bib69","series-title":"Nature Genetics","first-page":"491","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","unstructured":"Estrada KStyrkarsdottir UEvangelou EHsu YHDuncan ELNtzani EEOei LAlbagha OMEAmin NKemp JP, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics 2012 44 491\u2013501. (https:\/\/doi.org\/10.1038\/ng.2249)"},{"key":"bib70","series-title":"Pediatric Blood and Cancer","first-page":"2212","article-title":"Genetic variation and bone mineral density in long-term adult survivors of childhood cancer","volume":"63","author":"den Hoed","year":"2016","unstructured":"den Hoed MAHPluijm SMFStolk LUitterlinden AGPieters R & van den Heuvel-Eibrink MM. Genetic variation and bone mineral density in long-term adult survivors of childhood cancer. Pediatric Blood and Cancer 2016 63 2212\u20132220. (https:\/\/doi.org\/10.1002\/pbc.26198)"},{"key":"bib71","series-title":"Journal of Clinical Oncology","first-page":"3031","article-title":"CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia","volume":"26","author":"Jones","year":"2008","unstructured":"Jones TSKaste SCLiu WCheng CYang WTantisira KGPui C-H & Relling MV. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. Journal of Clinical Oncology 2008 26 3031\u20133037. (https:\/\/doi.org\/10.1200\/JCO.2007.14.6399)"},{"key":"bib72","series-title":"Pharmacogenomics","first-page":"409","article-title":"Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors","volume":"20","author":"Aaron","year":"2019","unstructured":"Aaron MNadeau GOuimet-Grennan EDrouin SBertout LBeaulieu PSt-Onge PShalmiev AVeilleux L-NRauch F, et al. Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors. Pharmacogenomics 2019 20 409\u2013420. (https:\/\/doi.org\/10.2217\/pgs-2018-0169)"},{"key":"bib73","series-title":"Journal of Bone and Mineral Research","first-page":"130","article-title":"Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors","volume":"39","author":"Genevi\u00e8ve","year":"2024","unstructured":"Genevi\u00e8ve NMojgan YNahid YVincenzo FSimon GDaniel SMaja KNathalie A & Despoina M. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors. Journal of Bone and Mineral Research 2024 39 130\u2013138. (https:\/\/doi.org\/10.1093\/jbmr\/zjad013)"},{"key":"bib74","series-title":"Cancer","first-page":"5920","article-title":"Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"118","author":"Wilson","year":"2012","unstructured":"Wilson CLDilley KNess KKLeisenring WLSklar CAKaste SCStovall MGreen DMArmstrong GTRobison LL, et al. Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2012 118 5920\u20135928. (https:\/\/doi.org\/10.1002\/cncr.27626)"},{"key":"bib75","series-title":"Cancer Causes and Control","first-page":"1047","article-title":"Hospitalization and mortality among pediatric cancer survivors: a population-based study","volume":"29","author":"Mueller","year":"2018","unstructured":"Mueller BADoody DRWeiss NS & Chow EJ. Hospitalization and mortality among pediatric cancer survivors: a population-based study. Cancer Causes and Control 2018 29 1047\u20131057. (https:\/\/doi.org\/10.1007\/s10552-018-1078-0)"},{"key":"bib76","series-title":"Pediatric Blood and Cancer","first-page":"936","article-title":"QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history","volume":"47","author":"Kaste","year":"2006","unstructured":"Kaste SCTong XHendrick JMKarimova EJSrivastava DKTylavsky FASnider TL & Carbone LD. QCT versus DXA in 320 survivors of childhood cancer: association of BMD with fracture history. Pediatric Blood and Cancer 2006 47 936\u2013943. (https:\/\/doi.org\/10.1002\/pbc.20854)"},{"key":"bib77","series-title":"Cancer","first-page":"202","article-title":"Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health","volume":"126","author":"Bloomhardt","year":"2020","unstructured":"Bloomhardt HMSint KRoss WLRotatori JNess KRobinson CCarpenter TOChow EJ & Kadan-Lottick NS. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health. Cancer 2020 126 202\u2013210. (https:\/\/doi.org\/10.1002\/cncr.32512)"},{"key":"bib78","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"512","article-title":"Predictors of vertebral deformity in long-term survivors of childhood acute lymphoblastic leukemia: the PETALE study","volume":"106","author":"Fiscaletti","year":"2021","unstructured":"Fiscaletti MSamoilenko MDubois JMiron MCLefebvre GKrajinovic MLaverdi\u00e8re CSinnett D & Alos N. Predictors of vertebral deformity in long-term survivors of childhood acute lymphoblastic leukemia: the PETALE study. Journal of Clinical Endocrinology and Metabolism 2021 106 512\u2013525. (https:\/\/doi.org\/10.1210\/clinem\/dgaa806)"},{"key":"bib79","series-title":"Lancet. Oncology","first-page":"489","article-title":"Long-term follow-up of people who have survived cancer during childhood","volume":"7","author":"Skinner","year":"2006","unstructured":"Skinner RWallace WHBLevitt GA & UK Children\u2019s Cancer Study Group Late Effects Group. Long-term follow-up of people who have survived cancer during childhood. Lancet. Oncology 2006 7 489\u2013498. (https:\/\/doi.org\/10.1016\/S1470-2045(06)70724-0)"},{"key":"bib80","series-title":"Scottish Intercollegiate Guidelines Network","article-title":"Long term follow up of survivors of childhood cancer: a national clinical guideline (SIGN Guideline No 132)","year":"2013","unstructured":"Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer: a national clinical guideline (SIGN Guideline No 132) (March). Scottish Intercollegiate Guidelines Network, 2013. (https:\/\/www.sign.ac.uk\/media\/1070\/sign132.pdf)"},{"key":"bib81","unstructured":"Children\u2019s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, Version 5.0. Monrovia, CA, USA: Children's Oncology Group. (www.survivorshipguidelines.org)"},{"key":"bib82","year":"2010","unstructured":"Dutch Childhood Oncology Group. Richtlijn follow-up na kinderkanker meer dan 5 jaar na diagnose. Den Haag\/Amsterdam: SKION, 2010. (www.skion.nl)"},{"key":"bib83","series-title":"Frontiers in Endocrinology","first-page":"1082413","article-title":"Bone health in childhood and adolescence: an overview on dual-energy x-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries","volume":"14","author":"Madhuchani","year":"2023","unstructured":"Madhuchani DSeneviratne SN & Ward LM. Bone health in childhood and adolescence: an overview on dual-energy x-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries. Frontiers in Endocrinology 2023 14 1082413. (https:\/\/doi.org\/10.3389\/fendo.2023.1082413)"},{"key":"bib84","series-title":"Cancer Medicine","first-page":"4177","article-title":"Vitamin D supplementation for children with cancer: a systematic review and consensus recommendations","volume":"10","author":"van Atteveld","year":"2021","unstructured":"van Atteveld JEVerhagen IEvan den Heuvel-Eibrink MMvan Santen HMvan der Sluis IMDi Iorgi NSimmons JHWard LM & Neggers SJCMM. Vitamin D supplementation for children with cancer: a systematic review and consensus recommendations. Cancer Medicine 2021 10 4177\u20134194. (https:\/\/doi.org\/10.1002\/cam4.4013)"},{"key":"bib85","series-title":"Lancet. Diabetes and Endocrinology","first-page":"2","article-title":"Long-term bone health in childhood cancer survivors: underappreciated and undertreated?","volume":"11","author":"Link-Rachner","year":"2023","unstructured":"Link-Rachner CS & Rachner TD. Long-term bone health in childhood cancer survivors: underappreciated and undertreated? Lancet. Diabetes and Endocrinology 2023 11 2\u20133. (https:\/\/doi.org\/10.1016\/S2213-8587(22)00315-1)"},{"key":"bib86","series-title":"New England Journal of Medicine","first-page":"382","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","unstructured":"Adachi JDBensen WGBrown JHanley DHodsman AJosse RKendler DLLentle BOlszynski WSte-Marie LG, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. New England Journal of Medicine 1997 337 382\u2013387. (https:\/\/doi.org\/10.1056\/NEJM199708073370603)"},{"key":"bib87","series-title":"New England Journal of Medicine","first-page":"2547","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Buckley","year":"2018","unstructured":"Buckley L & Humphrey MB. Glucocorticoid-induced osteoporosis. New England Journal of Medicine 2018 379 2547\u20132556. (https:\/\/doi.org\/10.1056\/NEJMcp1800214)"},{"key":"bib88","series-title":"Frontiers in Endocrinology","first-page":"1266986","article-title":"A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence","volume":"14","author":"Ward","year":"2023","unstructured":"Ward LM. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence. Frontiers in Endocrinology 2023 14 1266986. (https:\/\/doi.org\/10.3389\/fendo.2023.1266986)"},{"key":"bib89","series-title":"Osteoporosis International","first-page":"2147","article-title":"The management of osteoporosis in children","volume":"27","author":"Ward","year":"2016","unstructured":"Ward LMKonji VN & Ma J. The management of osteoporosis in children. Osteoporosis International 2016 27 2147\u20132179. (https:\/\/doi.org\/10.1007\/s00198-016-3515-9)"},{"key":"bib90","series-title":"Journal of Oral and Maxillofacial Research","first-page":"e1","article-title":"Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta","volume":"4","author":"Hennedige","year":"2013","unstructured":"Hennedige AAJayasinghe JKhajeh J & Macfarlane TV. Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta. Journal of Oral and Maxillofacial Research 2013 4 e1. (https:\/\/doi.org\/10.5037\/jomr.2013.4401)"},{"key":"bib91","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1333","article-title":"Bisphosphonate treatment and the characteristics of femoral fractures in children with osteogenesis imperfecta","volume":"102","author":"Vuorimies","year":"2017","unstructured":"Vuorimies IM\u00e4yr\u00e4np\u00e4\u00e4 MKValta HKr\u00f6ger HToiviainen-Salo S & M\u00e4kitie O. Bisphosphonate treatment and the characteristics of femoral fractures in children with osteogenesis imperfecta. Journal of Clinical Endocrinology and Metabolism 2017 102 1333\u20131339. (https:\/\/doi.org\/10.1210\/jc.2016-3745)"},{"key":"bib92","series-title":"Journal of Pediatric Hematology\/Oncology","first-page":"200","article-title":"Safety and efficacy of alendronate to treat osteopenia in children during therapy for acute lymphoblastic leukemia: a retrospective cohort study of sequential outcomes","volume":"45","author":"MacDonald","year":"2023","unstructured":"MacDonald PCranston AVirdee MFarncombe TAthale U & Barr RD. Safety and efficacy of alendronate to treat osteopenia in children during therapy for acute lymphoblastic leukemia: a retrospective cohort study of sequential outcomes. Journal of Pediatric Hematology\/Oncology 2023 45 200\u2013206. (https:\/\/doi.org\/10.1097\/MPH.0000000000002606)"},{"key":"bib93","series-title":"Pediatric Blood and Cancer","first-page":"e28723","article-title":"Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma","volume":"67","author":"van Iersel","year":"2020","unstructured":"van Iersel Lvan Santen HMPotter BLi ZConklin HMZhang HChemaitilly W & Merchant TE. Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma. Pediatric Blood and Cancer 2020 67 e28723. (https:\/\/doi.org\/10.1002\/pbc.28723)"},{"key":"bib94","series-title":"Journal of Clinical Oncology","first-page":"492","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study","volume":"33","author":"Chemaitilly","year":"2015","unstructured":"Chemaitilly WLi ZHuang SNess KKClark KLGreen DMBarnes NArmstrong GTKrasin MJSrivastava DK, et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study. Journal of Clinical Oncology 2015 33 492\u2013500. (https:\/\/doi.org\/10.1200\/JCO.2014.56.7933)"},{"key":"bib95","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"852","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","unstructured":"Barake MKlibanski A & Tritos NA. Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2014 99 852\u2013860. (https:\/\/doi.org\/10.1210\/jc.2013-3921)"},{"key":"bib96","series-title":"Clinical Endocrinology","first-page":"727","article-title":"Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study","volume":"81","author":"Appelman-Dijkstra","year":"2014","unstructured":"Appelman-Dijkstra NMClaessen KMJAHamdy NATPereira AM & Biermasz NR. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study. Clinical Endocrinology 2014 81 727\u2013735. (https:\/\/doi.org\/10.1111\/cen.12493)"},{"key":"bib97","series-title":"JAMA","first-page":"2668","article-title":"Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women","volume":"287","author":"Lindsay","year":"2002","unstructured":"Lindsay RGallagher JCKleerekoper M & Pickar JH. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002 287 2668\u20132676. (https:\/\/doi.org\/10.1001\/jama.287.20.2668)"},{"key":"bib98","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2386","article-title":"Long-term effect of testosterone therapy on bone mineral density in hypogonadal men","volume":"82","author":"Behre","year":"1997","unstructured":"Behre HMKliesch SLeifke ELink TM & Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 1997 82 2386\u20132390. (https:\/\/doi.org\/10.1210\/jcem.82.8.4163)"},{"key":"bib99","series-title":"European Journal of Endocrinology","first-page":"P35","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","unstructured":"Boguszewski MCSBoguszewski CLChemaitilly WCohen LEGebauer JHigham CHoffman ARPolak MYuen KCJAlos N, et al. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. European Journal of Endocrinology 2022 186 P35\u2013P52. (https:\/\/doi.org\/10.1530\/EJE-21-1186)"},{"key":"bib100","series-title":"Endocrine Development","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000316129","article-title":"Clinical considerations in using growth hormone therapy in growth hormone deficiency","volume":"18","author":"Ranke","year":"2010","unstructured":"Ranke MB. Clinical considerations in using growth hormone therapy in growth hormone deficiency. Endocrine Development 2010 18 83\u201391. (https:\/\/doi.org\/10.1159\/000316129)"},{"key":"bib101","series-title":"Endocrine","first-page":"267","article-title":"The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke","volume":"56","author":"Jasim","year":"2017","unstructured":"Jasim SAlahdab FAhmed ATTamhane SUSharma ADonegan DNippoldt TB & Murad MH. The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke. Endocrine 2017 56 267\u2013278. (https:\/\/doi.org\/10.1007\/s12020-016-1156-6)"},{"key":"bib102","series-title":"Lancet. Diabetes and Endocrinology","first-page":"683","article-title":"Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study","volume":"8","author":"S\u00e4vendahl","year":"2020","unstructured":"S\u00e4vendahl LCooke RTidblad ABeckers DButler GCianfarani SClayton PCoste JHokken-Koelega ACSKiess W, et al. Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study. Lancet. Diabetes and Endocrinology 2020 8 683\u2013692. (https:\/\/doi.org\/10.1016\/S2213-8587(20)30163-7)"},{"key":"bib103","series-title":"European Journal of Endocrinology","first-page":"471","article-title":"Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer","volume":"183","author":"Thomas-Teinturier","year":"2020","unstructured":"Thomas-Teinturier COliver-Petit IPacquement HFresneau BAllodji RSVeres CBolle SBerchery DDemoor-Goldschmidt CHaddy N, et al. Influence of growth hormone therapy on the occurrence of a second neoplasm in survivors of childhood cancer. European Journal of Endocrinology 2020 183 471\u2013480. (https:\/\/doi.org\/10.1530\/EJE-20-0369)"},{"key":"bib104","series-title":"Best Practice and Research. Clinical Endocrinology and Metabolism","first-page":"317","article-title":"Hormone replacement therapy: controversies, pros and cons.","volume":"18","author":"Warren","year":"2004","unstructured":"Warren MP & Halpert S. Hormone replacement therapy: controversies, pros and cons. Best Practice and Research. Clinical Endocrinology and Metabolism 2004 18 317\u2013332. (https:\/\/doi.org\/10.1016\/j.beem.2004.02.005)"},{"key":"bib105","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1715","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","unstructured":"Bhasin SBrito JPCunningham GRHayes FJHodis HNMatsumoto AMSnyder PJSwerdloff RSWu FC & Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2018 103 1715\u20131744. (https:\/\/doi.org\/10.1210\/jc.2018-00229)"},{"key":"bib106","series-title":"Endocrine Reviews","first-page":"7","article-title":"Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors","volume":"43","author":"van Iersel","year":"2022","unstructured":"van Iersel LMulder RLDenzer CCohen LESpoudeas HAMeacham LRSugden ESchouten-van Meeteren AYNHoving EWPacker RJ, et al. Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors. Endocrine Reviews 2022 43 794\u2013823. (https:\/\/doi.org\/10.1210\/endrev\/bnab040)"},{"key":"bib107","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"5212","article-title":"Efficacy and safety of human parathyroid hormone-(1\u201384) in increasing bone mineral density in postmenopausal osteoporosis","volume":"88","author":"Hodsman","year":"2003","unstructured":"Hodsman ABHanley DAEttinger MPBolognese MAFox JMetcalfe AJ & Lindsay R. Efficacy and safety of human parathyroid hormone-(1\u201384) in increasing bone mineral density in postmenopausal osteoporosis. Journal of Clinical Endocrinology and Metabolism 2003 88 5212\u20135220. (https:\/\/doi.org\/10.1210\/jc.2003-030768)"},{"key":"bib108","series-title":"New England Journal of Medicine","first-page":"821","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","unstructured":"McClung MRLewiecki EMCohen SBBolognese MAWoodson GCMoffett AHPeacock MMiller PDLederman SNChesnut CH, et al. Denosumab in postmenopausal women with low bone mineral density. New England Journal of Medicine 2006 354 821\u2013831. (https:\/\/doi.org\/10.1056\/NEJMoa044459)"},{"key":"bib109","series-title":"Journal of Bone and Mineral Research","first-page":"19","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","unstructured":"Padhi DJang GStouch BFang L & Posvar E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. Journal of Bone and Mineral Research 2011 26 19\u201326. (https:\/\/doi.org\/10.1002\/jbmr.173)"},{"key":"bib110","series-title":"Journal of Bone and Mineral Research","first-page":"242","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect","volume":"26","author":"Eisman","year":"2011","unstructured":"Eisman JABone HGHosking DJMcClung MRReid IRRizzoli RResch HVerbruggen NHustad CMDaSilva C, et al. Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. Journal of Bone and Mineral Research 2011 26 242\u2013251. (https:\/\/doi.org\/10.1002\/jbmr.212)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/13\/12\/EC-24-0487.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/12\/EC-24-0487.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/13\/12\/EC-24-0487.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:30Z","timestamp":1784555250000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":110,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0487","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]}}}